(Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve opioid related claims against the drugmaker.
The opioid litigation has already yielded more than $50 billion in settlements from drugmakers and pharmacies facing thousands of lawsuits by local governments across the United States.
Viatris said it would pay between $27.5 million to $40 million annually toward state and local opioid initiatives, but maintained that the settlement does not constitute an admission of wrongdoing or liability.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar and Tasim Zahid)
Comments